机构:[1]Department of Otorhinolaryngology Head and Neck Surgery, Department of Allergy, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China临床科室耳鼻咽喉-头颈外科变态反应科首都医科大学附属北京同仁医院首都医科大学附属同仁医院[2]Beijing Institute of Otolaryngology, Beijing Laboratory of Allergic Diseases, Beijing Key Laboratory of New Medicine and Diagnostic Technology Research for Nasal Disease, Key Laboratory of Otolaryngology Head and Neck Surgery, Ministry of Education, Capital Medical University, Beijing 100005, China研究所耳鼻咽喉科研究所首都医科大学附属北京同仁医院首都医科大学附属同仁医院[3]Research Unit of Diagnosis and Treatment of Chronic Nasal Diseases, Chinese Academy of Medical Sciences, Beijing 100005, China
National Natural Science Foundation of China (81700887, 81970851, 82271140 and 82371115),Beijing Nova Program (20220484198), Changjiang Scholars and Innovative Research Team (IRT13082), Capital’s Funds for Health
Improvement and Research (2022–1-1091), National Key Research and
Development Program of China (2022YFC2504100), the Public Welfare
Development and Reform Pilot Project (2019–10), and Beijing Municipal Public Welfare Development and Reform Pilot Project for Medical
Research Institutes (JYY2021–2 and JYY2023–1).
第一作者机构:[1]Department of Otorhinolaryngology Head and Neck Surgery, Department of Allergy, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China
共同第一作者:
通讯作者:
通讯机构:[1]Department of Otorhinolaryngology Head and Neck Surgery, Department of Allergy, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China[2]Beijing Institute of Otolaryngology, Beijing Laboratory of Allergic Diseases, Beijing Key Laboratory of New Medicine and Diagnostic Technology Research for Nasal Disease, Key Laboratory of Otolaryngology Head and Neck Surgery, Ministry of Education, Capital Medical University, Beijing 100005, China[3]Research Unit of Diagnosis and Treatment of Chronic Nasal Diseases, Chinese Academy of Medical Sciences, Beijing 100005, China
推荐引用方式(GB/T 7714):
Zhang Yuling,Yang Mengzhe,Li Yan,et al.Role of CD44+CCR2+CD64-monocyte-derived macrophage in chronic rhinosinusitis with nasal polyps[J].Cellular Immunology.2025,411:104953.doi:10.1016/j.cellimm.2025.104953.
APA:
Zhang Yuling,Yang Mengzhe,Li Yan,Wang Zaichuan,Zhang Shujian...&Zhang Luo.(2025).Role of CD44+CCR2+CD64-monocyte-derived macrophage in chronic rhinosinusitis with nasal polyps.Cellular Immunology,411,
MLA:
Zhang Yuling,et al."Role of CD44+CCR2+CD64-monocyte-derived macrophage in chronic rhinosinusitis with nasal polyps".Cellular Immunology 411.(2025):104953